ZVRA - Zevra Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

251.9M

Cash

52.72M

Avg Qtr Burn

-11.41M

Short % of Float

8.79%

Insider Ownership

8.41%

Institutional Own.

33.26%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AZSTARYS (KP415) (serdexmethylphenidate and dexmethylphenidate) Details Attention deficit hyperactivity disorder	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
APADAZ (benzhydrocodone and acetaminophen) Details Acute pain	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Arimoclomol (Heat-Shock Protein (HSP) amplifier) Details Rare genetic disease, Rare diseases, Niemann Pick Disease Type C Big Mover™ Suspected Mover™ Susp. Mover™	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Arimoclomol (Heat-Shock Protein (HSP) amplifier) Details Rare diseases, Rare genetic disease, Niemann Pick Disease Type C Big Mover™ Suspected Mover™ Susp. Mover™	PDUFA Adcomm	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Celiprolol Details Vascular Ehlers-Danlos Syndrome	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KP1077 (serdexmethylphenidate, SDX) Details EDS in Idiopathic Hypersomnia	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KP1077 (serdexmethylphenidate, SDX) Details Narcolepsy, Sleeping disorder	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KP879 (Methylphenidate) Details Stimulant Use Disorder	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.